Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 109, Issue 2, Pages 452-461
Publisher
Springer Nature
Online
2013-06-28
DOI
10.1038/bjc.2013.305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
- (2012) Sergio Marchini et al. EUROPEAN JOURNAL OF CANCER
- ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
- (2012) David A Tumbarello et al. Molecular Cancer
- A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma
- (2011) J. M. Shohet et al. CANCER RESEARCH
- Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells
- (2010) Yoshihiro Takeyama et al. CANCER LETTERS
- Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors
- (2010) S. Ohashi et al. CANCER RESEARCH
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-β1-mediated growth suppression in adult T-cell leukemia/lymphoma
- (2010) S Nakahata et al. ONCOGENE
- miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
- (2009) L. Adam et al. CLINICAL CANCER RESEARCH
- MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
- (2009) Todd Boren et al. GYNECOLOGIC ONCOLOGY
- Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
- (2009) Ram Eitan et al. GYNECOLOGIC ONCOLOGY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- The role of the ZEB family of transcription factors in development and disease
- (2008) C. Vandewalle et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
- (2008) I. Ivanovska et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now